(Q24247236)

20 October 2023

João Costa

1

J

Costa

1 reference

20 October 2023

Cláudia C Espírito-Santo

2

C

Espírito-Santo

1 reference

20 October 2023

Ana A Borges

3

A

Borges

1 reference

20 October 2023

Joaquim Ferreira

4

J J

Ferreira

1 reference

20 October 2023

Miguel M Coelho

5

M

Coelho

1 reference

20 October 2023

Peter Moore

6

P

Moore

1 reference

Cochrane Database of Systematic Reviews

20 October 2023

publication date

19 April 2004

0 references

published in

0 references

cites work

Pretarsal application of botulinum toxin for treatment of blepharospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Botulinum a toxin treatment of hemifacial spasm and blepharospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Statistics notes. Interaction 1: Heterogeneity of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Pathophysiology of blepharospasm and oromandibular dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Blepharospasm: a case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Blepharospasm: a review of 264 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Blepharospasm: Successful treatment with clonazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Epidemiology of focal and generalized dystonia in Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Hysterical blepharospasm treated by psychotherapy and conditioning procedures in a group setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Meiges disease: a clinical form of facial convulsion, bilateral and medial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Quality of life in patients with blepharospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Hypnosis and Biofeedback as Adjunctive Therapy in Blepharospasm: A Case Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Blepharospasm surgery. An anatomical approach

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Botulinum A toxin injection as a treatment for blepharospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

The use of EMG feedback in the treatment of a severe case of blepharospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Case Report of Successful Treatment of a Reflex Trigeminal Nerve Blepharospasm by Behavior Modification

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

The significance of ophthalmological symptoms in idiopathic blepharospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Hypnosis and broad-spectrum behavior therapy for blepharospasm: a case study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Biofeedback in the treatment of blepharospasm: a case study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Behaviour Therapy in a Case of Blepharospasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004900.PUB2

7 January 2021

10.1002/14651858.CD004900.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_safmcty7sfbj3kclbkh6apxasu

0 references